Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis - Phase II Single Center Study
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs IP10.C8 (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 16 Oct 2009 New trial record.